Back

Prevalence and risk of DOACs inappropriate dosing in atrial fibrillation. An analysis of the Swiss-AF and BEAT-AF registries

1 September 2019 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster Session 2 - Drug treatment for atrial fibrillation Oral Anticoagulation ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Giulia Montrasio

Kantonsspital Aarau, Aarau (Switzerland)

9 More presentations in this session

Presentation thumbnail
Doctor W. Amara (Le Raincy-Montfermeil, FR)
Abstract
Presentation thumbnail
Doctor M. Mihajlovic (Belgrade, RS)
Abstract Slides
Presentation thumbnail
Associate Professor M. Harada (Toyoake, JP)
Abstract
Presentation thumbnail
Doctor O. Hajas (Debrecen, HU)
Abstract Slides
Presentation thumbnail
Professor H. Crijns (Maastricht, NL)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 2 - Drug treatment for atrial fibrillation

The Event

Event poster

ESC Congress 2019

1 September 2019 08:30 CET
You may be interested in
thumbnail
Congress Session
Stroke prevention in clinical and subclinical atrial fibrillation
thumbnail
Congress Presentation
State-of-the-art lecture on stroke and bleeding risk in atrial fibrillation: walking the tight rope
thumbnail
Congress Session
Oral anticoagulation in subclinical atrial fibrillation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources